EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Supporting Pediatric RSV Clinical Trials Through Close Epidemiological Surveillance During the SARS ‐ CoV ‐2 Pandemic

Rennie Joshi iD, Georges J Nahhas, Carmen S Arriola, Patricia Saddier, Andrea Guerra

Pharmacology Research & Perspectives · 2025

DOI: 10.1002/prp2.70112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2025. Verfasst von Rennie Joshi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Merck Sharp & Dohme LLC, Rahway, New Jersey, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, COVID-19, Clinical Trials as Topic, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Merck.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clesrovimab, an extended half‐life monoclonal antibody, aims to protect infants for an entire RSV season. The pandemic impacted RSV epidemiology and strategies were implemented to support clesrovimab trials. Near real‐time monitoring of data showed minimal RSV activity in 2020. In 2021, RSV resurged early in some countries and was delayed in others, resulting in a change in trial enrollment strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsCOVID-19Clinical Trials as TopicAntibodies, Monoclonal, HumanizedAntiviral AgentsHumansInfantEpidemiological MonitoringChildSARS-CoV-2Pandemics

Stichwörter der Autor:innen

COVID‐19RSVclesrovimabepidemiologysurveillance

Substanzen

Antibodies, Monoclonal, HumanizedAntiviral Agents

Autor:innen und Institutionen

  • Merck Sharp & Dohme LLC, Rahway, New Jersey, USA.

ORCID-Profile: Rennie Joshi

Förderung

  • Merck

Zitieren

APA

Joshi, R., Nahhas, G. J., Arriola, C. S., Saddier, P., & Guerra, A. (2025). Supporting Pediatric RSV Clinical Trials Through Close Epidemiological Surveillance During the SARS ‐ CoV ‐2 Pandemic. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70112

Vancouver

Joshi R, Nahhas GJ, Arriola CS, Saddier P, Guerra A. Supporting Pediatric RSV Clinical Trials Through Close Epidemiological Surveillance During the SARS ‐ CoV ‐2 Pandemic. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70112

BibTeX
@article{Joshi2025,
  author = {Joshi, Rennie and Nahhas, Georges J and Arriola, Carmen S and Saddier, Patricia and Guerra, Andrea},
  title = {Supporting Pediatric RSV Clinical Trials Through Close Epidemiological Surveillance During the SARS ‐ CoV ‐2 Pandemic},
  journal = {Pharmacology Research & Perspectives},
  year = {2025},
  doi = {10.1002/prp2.70112}
}
Kostenlos starten →